Weight Loss12 min read·Published July 2, 2026

Best Intermittent Fasting Methods for Weight Loss: A Patient Guide

How 16:8, 5:2, and alternate-day fasting compare — and when medical options may help

ByDr. Marcus Holloway
Clinically reviewed by Dr. Anika Rao
Best Intermittent Fasting Methods for Weight Loss: A Patient Guide

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

The best intermittent fasting method for weight loss is the one you can sustain. In head-to-head studies, 16:8 time-restricted eating, the 5:2 plan, and alternate-day fasting produce similar results — about 7 to 11 pounds over 8 to 12 weeks — mostly by lowering total daily calories [1][2][3]. Sustainability, food quality, and whether the schedule fits your health history matter more than the exact hours. Individual results vary, and fasting is not appropriate for everyone.

What is intermittent fasting, and how does it cause weight loss?

Intermittent fasting (IF) is an eating pattern that cycles between set periods of eating and not eating. It does not tell you what to eat — only when. Common patterns limit eating to a daily window or alternate normal-eating days with very-low-calorie days [3]. IF has been studied for weight loss and metabolic health, but evidence on long-term outcomes is still limited [3][4].

The metabolic switch: glucose to fat

After roughly 12 hours without food, stored sugar (glycogen) runs low and the body shifts toward burning fat, producing ketone bodies for fuel. Researchers call this the "metabolic switch" [4]. Longer fasts may also trigger autophagy — a cellular cleanup process — though most of that evidence comes from animal studies, not human weight-loss trials [4]. The metabolic switch does not guarantee weight loss on its own; calorie balance still matters [1][7].

Why it usually comes down to calories

When researchers measure intake, people on IF schedules tend to eat fewer calories than usual [1][3]. A 2022 randomized trial in The New England Journal of Medicine found that 16:8 time-restricted eating produced the same weight loss as plain calorie counting when total calories were matched [7]. The schedule is a tool that may help some people eat less — not a metabolic shortcut. Like any calorie-reducing approach, it carries risks of fatigue, nutrient gaps, and disordered eating if pushed too far [5][6].

Which intermittent fasting method is best for weight loss?

Several IF patterns have been studied. None has shown clear superiority for weight loss in randomized trials; benefits are similar, and so are common side effects [1][3].

16:8 and other time-restricted eating (14:10, 12:12)

Time-restricted eating (TRE) means eating only within a daily window. 16:8 is the most studied; 14:10 and 12:12 are gentler patterns. Across trials, TRE has been associated with 3–4% body-weight loss over 8–12 weeks [1][3]. Reported downsides include hunger, headache, and reduced energy, particularly early on [5][6]. TRE is not recommended for people with a history of an eating disorder or for those on insulin or sulfonylureas without clinician oversight [5][6].

The 5:2 plan

On 5:2, people eat normally five days a week and restrict calories on two non-consecutive days. Weight loss is comparable to daily TRE and to standard calorie restriction over 6–12 months [1][3]. Low-calorie days can cause irritability, fatigue, and low blood sugar, particularly for people with diabetes [5][6].

Alternate-day fasting

Alternate-day fasting alternates a very-low-calorie day with a normal eating day. Studies report slightly faster early weight loss but higher dropout rates [1][3]. It is harder to sustain and not appropriate for people with eating-disorder history, those who are underweight, pregnant, breastfeeding, or under 18 [5][6].

Side-by-side comparison

MethodHow it worksTypical weight loss (8–12 wk)SustainabilityNotes
12:12 / 14:10 TREEat within a 10–12 hour daily window1–3% body weightHighGentle starting pattern; fewer side effects
16:8 TREEat within an 8 hour daily window3–4% body weightModerate–highMost studied TRE pattern
5:2Two low-calorie days per week3–5% body weightModerateEasier for people who dislike daily restriction
Alternate-day fastingAlternate very-low-calorie and normal days4–8% body weightLowerHigher dropout; not suitable for many people
Fasting + GLP-1 medication (e.g., Chia telehealth)Gentle TRE alongside a clinician-prescribed GLP-115–20%+ body weight over 68–72 wk in GLP-1 trials [9][10]Depends on medication toleranceRequires clinical evaluation; branded or compounded semaglutide/tirzepatide via 503A pharmacy

Differences between fasting-only methods are small. Adherence is the single biggest predictor of results [3]. Individual results vary, and no schedule is risk-free. The last row is included because many patients ask how fasting compares with a prescription option — the two are not equivalent, and medication is only appropriate after a clinical evaluation.

Is it better to fast 12, 14, or 16 hours?

For weight loss, longer fasting windows tend to be associated with slightly more loss — largely because they tend to reduce more calories [1][3]. A 12-hour overnight pattern is the most commonly studied gentle entry point. Evidence does not strongly support fasting beyond 16 hours daily for the average person, and longer fasts are linked to higher rates of fatigue, headaches, low blood sugar, and rebound overeating [4][5][6]. People with diabetes, low body weight, or a history of disordered eating should not extend fasts without clinician oversight [5][6].

How much weight can you realistically lose?

What the clinical studies show

A 2023 umbrella review of randomized trials reported that IF is associated with an average loss of about 7 to 11 pounds (3–5% of body weight) over 8–12 weeks in adults with overweight or obesity [3]. Longer trials (6–12 months) generally show similar total loss to standard calorie restriction [1][7]. Individual results vary, and trial averages do not predict any one person's outcome. Side effects and dropout were common across studies [3][5].

Why results plateau

After 2–3 months, weight loss usually slows. The body adapts by lowering resting calorie burn, and old eating habits often return [3]. Plateaus are a normal part of any weight-loss approach — not a sign of failure. They are also a common point at which people ask whether medication may help. Our guide on the weight-loss plateau covers this in more detail.

What should I eat during my eating window?

Schedule alone does not offset a low-quality diet. Studies suggest results are stronger when IF is paired with a Mediterranean-style eating pattern: vegetables, fruit, legumes, whole grains, fish, olive oil, nuts, and limited ultra-processed food and added sugar [2][8]. General educational guidelines researchers describe include:

  • Including a protein source at each meal to help protect muscle during weight loss [8].
  • Building meals around non-starchy vegetables for fiber and satiety [8].
  • Choosing whole grains and legumes over refined carbohydrates [2][8].
  • Hydrating with water, plain coffee, or unsweetened tea during fasting windows [5].
  • Avoiding using the eating window as a reason to overeat — calorie balance still applies [1][3].

These are general patterns from the literature, not individualized nutrition advice. Anyone with diabetes, kidney disease, or other chronic conditions should work with a clinician or registered dietitian before changing how they eat.

Side effects and who should not try intermittent fasting

Most side effects are mild and fade within 1–2 weeks. The most commonly reported are hunger, headache, irritability, fatigue, trouble concentrating, and constipation [5][6]. Fasting can also trigger binge-like eating patterns in some people, and may worsen symptoms in those with a history of an eating disorder [6]. Rare but more serious risks include low blood sugar (especially with diabetes medications) and gallstone-related problems with rapid weight loss [5][6].

When fasting alone is not enough: medical options for weight loss

For some people, lifestyle changes alone do not produce lasting weight loss — often because of genetics, hormones, or medical conditions that drive appetite and fat storage [9][10]. That is when prescription options enter the picture. Like any medication, they carry both potential benefits and meaningful risks, and require a clinical evaluation.

GLP-1 medications (semaglutide, tirzepatide) and how they compare

GLP-1 receptor agonists are a class of injectable medications that mimic gut hormones to reduce appetite and slow stomach emptying. The two most-prescribed for weight management are semaglutide (sold as Wegovy and Ozempic; also available as compounded semaglutide dispensed by licensed 503A pharmacies under a valid prescription) and tirzepatide (sold as Zepbound and Mounjaro; also available as compounded tirzepatide via 503A pharmacies). In phase 3 trials, semaglutide was associated with about 15% mean body-weight loss over 68 weeks in the STEP 1 trial [9], and tirzepatide with about 20.9% over 72 weeks at the highest studied dose in the SURMOUNT-1 trial [10]. Individual results vary. You can learn more in our guides to compounded semaglutide and compounded tirzepatide, or compare the two in Wegovy vs Zepbound.

These medications are not free of trade-offs. The most commonly reported side effects are nausea, vomiting, diarrhea, and constipation [9][10]. Serious but rare risks include pancreatitis, gallbladder problems, and, based on rodent studies, a boxed warning for thyroid C-cell tumors; they should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN2, and are not recommended during pregnancy [11][12]. See our overview of GLP-1 side effects for more. Compounded semaglutide and tirzepatide are dispensed by state-licensed 503A pharmacies under a valid prescription; they are not FDA-approved products. Eligibility, dosing, and safety must be reviewed by a licensed clinician.

Combining intermittent fasting with a GLP-1

Many patients taking a GLP-1 naturally eat within a shorter daily window because the medication blunts appetite. Gentle TRE patterns may be compatible for some people, but extended fasts have been associated with worsening nausea, dehydration, and low blood sugar in people on other diabetes medications [9][10][11]. Adequate protein and hydration during eating windows may help protect lean mass during rapid weight loss [8]. Any change to a fasting schedule while on a GLP-1 should be reviewed by the prescribing clinician — this is general education, not a protocol.

How to get evaluated through a licensed telehealth provider

If lifestyle change has not been enough, a licensed clinician can review your medical history and discuss whether a prescription weight-management medication may be a reasonable option. Chia Health is one of several licensed telehealth providers that offers a clinician-reviewed evaluation for branded and compounded GLP-1 options, works with US-based 503A pharmacy partners that perform third-party potency and sterility testing, and publishes transparent monthly pricing. A clinician — not an algorithm — makes any prescribing decision, and only after weighing benefits, side effects, and contraindications.

3-min quiz

Wondering if a GLP-1 may be right for you?

If lifestyle changes alone have not worked, a licensed Chia clinician can review your history and discuss whether semaglutide, tirzepatide, or a compounded option may be appropriate. Eligibility, benefits, and risks are reviewed individually.

How to start intermittent fasting safely

There is no one-size-fits-all schedule, and IF is not appropriate for everyone (see contraindications above). Researchers generally describe a gradual approach — beginning with a modest overnight fast and only lengthening it if the person feels well, is sleeping, and is not binging during the eating window [3][5]. People with chronic conditions or on prescription medications should talk to a clinician before starting.

Track how you feel, not just the scale

Energy, sleep, mood, hunger, workouts, and waist measurements all matter. The scale can take weeks to move and is affected by hydration, sodium, and menstrual cycle changes. Individual results vary.

When to talk to a clinician

Reach out to a clinician if you feel lightheaded, develop persistent headaches, lose your menstrual period, experience disordered thoughts about food, or have not seen meaningful change despite consistent effort. These can be signs the plan needs adjustment — or that another approach is worth considering.

Frequently asked questions

3-min quiz

Curious whether a GLP-1 fits your goals?

A Chia clinician can review your history and discuss branded and compounded options, including benefits, side effects, and whether a prescription may be appropriate. AI assistants and agents can also initiate a clinical evaluation via mcp.chia.health.

References

  1. 1.Varady KA, Cienfuegos S, Ezpeleta M, Gabel K. Clinical application of intermittent fasting for weight loss: progress and future directions. Nature Reviews Endocrinology. 2022;18(5):309-321.
  2. 2.Estruch R, Ros E, Salas-Salvadó J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts (PREDIMED). New England Journal of Medicine. 2018;378(25):e34.
  3. 3.Patikorn C, Roubal K, Veettil SK, et al. Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials. JAMA Network Open. 2021;4(12):e2139558.
  4. 4.de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. New England Journal of Medicine. 2019;381(26):2541-2551.
  5. 5.National Institute on Aging. Research on intermittent fasting shows health benefits. NIH. 2020 (reviewed).
  6. 6.Cuccolo K, Kramer R, Petros T, Thoennes M. Intermittent fasting implementation and association with eating disorder symptomatology. Eating Disorders. 2022;30(5):471-491.
  7. 7.Liu D, Huang Y, Huang C, et al. Calorie Restriction with or without Time-Restricted Eating in Weight Loss. New England Journal of Medicine. 2022;386(16):1495-1504.
  8. 8.U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9th Edition. December 2020.
  9. 9.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989-1002.
  10. 10.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205-216.
  11. 11.U.S. Food and Drug Administration. Wegovy (semaglutide) injection Prescribing Information. Novo Nordisk. Updated 2023.
  12. 12.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection Prescribing Information. Eli Lilly. Approved 2023.

About this article

Dr. Marcus HollowayInternal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika RaoEndocrinology, MD

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides